Interleukin-1β (Il-1β)-induced modulation of the hypothalamic Il-1β system, tumor necrosis factor-α, and transforming growth factor-β1 mRNAs in obese (fa/fa) and lean (fa/fa) Zucker rats: Implications to IL600-1β feedback systems and cytokine-cytokine interactions

Journal of Neuroscience Research

Volumn 49, Issue 5, 1997, Pages 541-550

  Plata Salamán, Carlos R ^a   Ilyin, Sergey E ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Growth factor; Hypothalamus; Interleukin; Neuroimmunology; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; HYPOTHALAMUS; IMMUNOMODULATION; IMMUNOREGULATION; MALE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; METABOLISM; OBESITY; PHYSIOLOGY; ZUCKER RAT;

ANIMALS; FEEDBACK; HYPOTHALAMUS; INTERLEUKIN-1; MALE; OBESITY; RATS; RATS, ZUCKER; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030609986     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19970901)49:5<541::AID-JNR4>3.0.CO;2-B     Document Type: Article

References (51)

1. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F (1996): Investigation on the expression of major histocompatibility complex II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol (Berl) 91:494-503.
2. Arend WP (1991): Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 88:1445-1451.
3. Chomczynski P (1993): A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15:532-537.
4. Ciardi M, Sharief MK, Thompson EJ, Salotti A, Vullo V, Sorice F, Cirelli A (1994): High cerebrospinal fluid and serum levels of tumor necrosis factor-α in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor. J Neurol Sci 125:175-179.
5. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993): Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
6. Cominelli F, Ferretti M, Nast CC, Ng R, Eisenberg SR Pizzarro TT (1993): Anti-interleukin-1 receptor antagonist treatment exacerbates and prolongs inflammation in rabbit immune colitis. Lymphokine Cytokine Res 12:340.
7. Cuff CA, Martiney JA, Berman JW, Brosnan CF (1996): Differential effects of transforming growth factor-β1 on interleukin-1-induced cellular inflammation and vascular permeability in the rabbit retina. J Neuroimmunol 70:21-28.
8. da Cunha A, Jefferson JJ, Jackson RW, Vitković L (1993a): Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J Neuroimmunol 42:71-86.
9. da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitković L (1993b): Control of astrocytosis by interleukin-1 and transforming growth factor-β1 in human brain. Brain Res 631:39-45.
10. Dinarello CA (1996): Biological basis for interleukin-1 in disease. Blood 87:2095-2147.
11. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C (1996): The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 125:191-196.
12. Dower SK, Bird TA, Sims JE (1992): Interleukin-1. Adv Neuroimmunol 2:1-16.
13. Ericsson A, Liu C, Hart RP, Sawchenko PE (1995): Type 1 interleukin-1 receptor in the rat brain: distribution, regulation and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 361:681-698.
14. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A (1989): Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23:109-116.
15. Glass JD, Johnson RT (1996): Human immunodeficiency virus and the brain. Annu Rev Neurosci 19:1-26.
16. Granowitz EV, Vannier E, Poutsiaka DD, Dinarello CA (1992): Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79:2364-2369.
17. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995): Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270:13757-13765.
18. Haour F, Marquette C, Ban E, Crumeyrolle-Arias M, Rostene W, Tsiang H, Fillion G (1995): Receptors for interleukin-1 in the central nervous and neuroendocrine systems. Ann Endocrinol (Paris) 56:173-179.
19. Hart RP, Liu C, Shadiack AM, McCormack RJ, Miller Jonakait G (1993): An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J Neuroimmunol 44:49-56.
20. Hotamisligil GS, Shargill NS, Spiegelman BM (1993): Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91.
21. Ilyin SE, Plata-Salamán CR (1996a): In vivo regulation of the [L-1β system (ligand, receptors I and II, receptor accessory protein and receptor antagonist) and TNF-α mRNAs in specific brain regions. Biochem Biophys Res Commun 227:861-867.
22. Ilyin SE, Plata-Salamán CR (1996b): An approach to study molecular mechanisms involved in cytokine-induced anorexia. J Neurosci Methods 70:33-38.
23. Ilyin SE, Plata-Salamán CR (1996c): Molecular regulation of the brain interleukin-1β system in obese (fa/fa) and lean (Fa/Fa) Zucker rats. Mol Brain Res 43:209-218.
24. Ilyin SE, Sonti G, Gayle D, Plata-Salamán CR (1996): Regulation of brain interleukin-1β (IL-1β) system mRNAs in response to pathophysiological concentrations of IL-1β in the cerebrospinal fluid. J Mol Neurosci 7:169-181.
25. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995): The expression of tumor necrosis factor in adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119.
26. Kuroda Y, Matsui M, Takashima H, Kurohara K (1993): Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 45:133-136.
27. Liu C, Chalmers D, Maki R, De Souza EB (1996): Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J Neuroimmunol 66:41-48.
28. López-Cortés LF, Cruz-Ruiz N, Gómez-Mateos J, Jiménez-Hernández D, Palomino J, Jiménez E (1993): Measurement of levels of tumor necrosis factor-α and interleukin-1β in the CSF of patients with meningitis of different etiologies: utility in the differential diagnosis. Clin Infect Dis 16:534-539.
29. Malinowsky D, Chai Z, Bristulf J, Simoncsits A, Bartfai T (1995): The type I interleukin-1 receptor mediates fever in the rat as shown by interleukin-1 receptor subtype selective ligands. Neurosci Lett 201:33-36.
30. Martel-Pelletier J, McCollum R, Pelletier J-P (1993): The synthesis of IL-1 receptor antagonist (IL-1Ra) by synovial fibroblasts is markedly increased by the cytokines TNF-α and IL-1. Biochim Biophys Acta 1175:302-305.
31. Mastroianni CM, Paoletti F, Valenti C, Vullo V, Jirillo E, Delia S (1992): Tumour necrosis factor (TNF-α) and neurological disorders in HIV infection. J Neurol Neurosurg Psychiatry 55:219-221.
32. Mazzolla R, Barluzzi R, Romani L, Mosci P, Bistoni F (1991): Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin 1. J Gen Microbiol 137:1799-1804.
33. Oldenburg HSA, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, Moldawer LL (1995): Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine 7:510-516.
34. Plata-Salamán CR (1991): Immunoregulators in the nervous system. Neurosci Biobehav Rev 15:185-215.
35. Plata-Salamán CR (1994): Meal patterns in response to the intracerebro-ventricular administration of interleukin-1β in rats. Physiol Behav 55:727-733.
36. Plata-Salamán CR (1995): Cytokines and feeding suppression: an integrative view from neurological to molecular levels. Nutrition 11:674-677.
37. Plata-Salamán CR (1996): Anorexia during acute and chronic disease. Nutrition 12:69-78.
38. Plata-Salamán CR, ffrench-Mullen JMH (1994): Interleukin-1β inhibits calcium channel currents in isolated hippocampal CA1 neurons through protein kinase C. Eur J Pharmacol 266:1-10.
39. Plata-Salamán CR, Sonti G, Borkoski JP, Wilson CD, ffrench-Mullen JMH (1996): Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 60:867-875.
40. Plata-Salamán CR, Vasselli JR, Sonti G (1997): Differential responsiveness of obese (fa/fa) and lean (Fa/Fa) Zucker rats to cytokine-induced anorexia. Obesity Res 5:36-42.
41. Rappolee DA, Mark D, Banda MJ, Werb Z (1988): Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 241:708-712.
42. Re F, Sironi M, Muzio N, Matteucci C, Introna M, Orlando S, Pentonrol G, Dower SK, Sims JE, Colotta F, Mantovani A (1996): Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin function. J Exp Med 183:1841-1850.
43. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SD (1993): Interleukin-1 signalling occurs exclusively via the type 1 receptor. Proc Natl Acad Sci USA 90:6155-6159.
44. Sonti G, Ilyin SE, Plata-Salamán CR (1996): Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 270:R1394-R1402.
45. Suzumura A, Sawada M, Yamamoto H, Marunouchi T (1993): Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J Immunol 151:2150-2158.
46. 2 and cAMP. Eur J Immunol 22:1221-1227.
47. Vergelli M, Mazzanti B, Ballerini C, Gran B, Amaducci L, Massacesi L (1995): Transforming growth factor-β1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J Neurosci Res 40:127-133.
48. Vitković L, da Cunha A, Tyor WR (1994): Cytokine expression and pathogenesis in AIDS brain. In Price RW, Perry SW (eds): "HIV, AIDS and the Brain." New York: Raven Press, pp 203-222.
49. Vogels MTE, Mensink EJBM, Ye K, Boerman OC, Verschueren CMM, Dinarello CA, van der Meer JWM (1994): Differential gene expression for IL-1 receptor antagonist. IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. J Immunol 153:5772-5780.
50. Wesche H, Neumann D, Resch K, Martin MU (1996): Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness. FEBS Lett 391:104-108.
51. Williams GT, McClanahan TK, Morimoto RI (1989): Ela transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex. Mol Cell Biol 9:2574-2587.